Regeneron Pharmaceuticals beats by $1.23, beats on revenue

|About: Regeneron Pharmaceutical... (REGN)|By:, SA News Editor

Regeneron Pharmaceuticals (NASDAQ:REGN): Q4 Non-GAAP EPS of $6.84 beats by $1.23; GAAP EPS of $7.15 beats by $1.73.

Revenue of $1.93B (+22.2% Y/Y) beats by $210M.

Press Release

Subscribe for full text news in your inbox